Table 1.
HLA-G 3′UTR haplotypes are associated with the clinical status of EOC patients.
| Metastasis formation | M1b | M0b | p a | OR (95% CI) |
|
|---|---|---|---|---|---|
| UTR-1 | UTR-1/UTR-1 | 5 | 1 | 0.0044 | 17.81 (1.94–163.7) |
| Remaining | 16 | 57 | |||
| Nodal status | pN 1 b | pN 0 b | p a |
OR
(95% CI) |
|
| UTR-5 | positive | 0 | 3 | 0.0392 | 0.066 (0.00–1.361) |
| negative | 33 | 15 | |||
| FIGO | III-IV b | I-II b | p a |
OR
(95% CI) |
|
| UTR-5 | positive | 1 | 3 | 0.001 | 0.014 (0.00–0.176) |
| negative | 72 | 3 |
CI – confidence interval; M0 – no metastasis formation; M1 – metastasis formation; pN0 – no nodal infestation; pN1 – nodal infestation; OR – odds ratio.
ap-values were calculated by GraphPad Prism using Fisher’s exact test, alpha <0.05.
bNumbers reflect cases.